Veterinary Medicines Biowaiver Application Form for Parenterals

The formulation and API characteristics, including the route of administration and species, are factors which may affect requirements to waive bioequivalence studies (i.e., to compare the rate and extent of absorption between two formulations containing same active substances). Applicants must submit the following relevant information in support of a biowaiver for parenterals.

Date updated

2022 Sept